Advancing Patient Care through Innovative
Practice: The Clinical Partners Program
Bella H. Mehta, Pharm.D., Jennifer L. Rodis, Pharm.D.,
Milap C. Nahata, Pharm.D., Marialice S. Bennett, B.S.Pharm.
The Ohio State University College of Pharmacy
Established in 1996, The Ohio State University College of
Pharmacy Clinical Partners Program has been a change agent
in the provision of innovative ambulatory care services. The
clinic is an active learning environment for students and
residents, offers a patient-focused practice model based on
pharmaceutical care principles, and serves as an arena for
applied research in ambulatory and community pharmacy practice.
Description of the Program
Clinical Partners is a pharmacist-managed ambulatory clinic
located in the outpatient clinic building. Services developed
at the site include practice in the areas of anticoagulation,
asthma, cholesterol, compliance, diabetes, hepatitis C, herbal
and dietary supplements, medication management, smoking cessation,
and wellness. The most successful methods of reimbursement
for programs have been 1) contracted services with OSU Managed
Health Care Systems Inc. to serve OSU faculty and staff and
2) for non-OSU patients, a fee-for-service charged directly
to the patient. The practice is staffed by two College of
Pharmacy faculty with a total of 0.8 FTE and a community pharmacy
resident who spends 65% of her time at the site. It has served
as a training site for 16 pharmacy residents, 28 undergraduate
pharmacy students, 30 postgraduate Pharm.D. students, and
126 entry-level Pharm.D. students at various levels of training.
Experience with the Program
Clinical Partners has consistently shown improved therapeutic
outcomes compared with traditional practice. In 2002, the
INR compliance rate for our anticoagulation management service
was 63%, compared with 38% within The Ohio State University
Medical Center using conventional care. Our local results
from participation in the APhA Foundation’s Project
Impact: Hyperlipidemia showed that 69% of our patients were
within 10% of their LDL goal, and our medication rates demonstrated
100% medication persistence and 96% medication compliance.
Preliminary aggregate results from the APhA Foundation’s
Patient Self-Management: Diabetes program illustrate a 1%
reduction in hemoglobin A1c and a 26% increase in patients
meeting a hemoglobin A1c goal of ≤ 7%. Impact on patient
satisfaction and quality of life are being measured in our
hepatitis C program and results will be submitted for publication.
Over the years, pharmacists at the Clinical Partners program
have had a positive impact on the health outcomes of hundreds
Drawing from its rich history of experience, Clinical Partners
anticipates a bright future as we continue to advance patient
care through innovative practice, education, and research.